These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12779077)

  • 1. Sequential changes in serum triglyceride levels during adjuvant tamoxifen therapy in breast cancer patients and the effect of dose reduction.
    Liu CL; Yang TL
    Breast Cancer Res Treat; 2003 May; 79(1):11-6. PubMed ID: 12779077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery.
    Hozumi Y; Kawano M; Miyata M
    Endocr J; 1997 Oct; 44(5):745-9. PubMed ID: 9466333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
    Wasan KM; Ramaswamy M; Haley J; Dunn BP
    J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels.
    Babu JR; Sundravel S; Arumugam G; Renuka R; Deepa N; Sachdanandam P
    Cancer Lett; 2000 Apr; 151(1):1-5. PubMed ID: 10766415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
    Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
    Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen therapy in breast cancer: do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?
    Gaibar M; Fernández G; Romero-Lorca A; Novillo A; Tejerina A; Bandrés F; Fernández-Santander A
    Int J Biol Markers; 2013 Dec; 28(4):e371-6. PubMed ID: 23828408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus.
    Milionis HJ; Liberopoulos EN; Elisaf MS
    Diabetes Metab; 2001 Apr; 27(2 Pt 1):160-3. PubMed ID: 11353883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer.
    Joensuu H; Holli K; Oksanen H; Valavaara R
    Breast Cancer Res Treat; 2000 Oct; 63(3):225-34. PubMed ID: 11110056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tamoxifen-induced severe hypertriglyceridemia--report of 3 cases].
    Koshizuka K; Serizawa M; Hasuda N; Furuya K; Mouri N; Takano K; Matsumoto M
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1109-12. PubMed ID: 15272596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
    Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
    Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women.
    Dziewulska-Bokiniec A; Wojtacki J; Skokowski J; Kortas B
    Neoplasma; 1994; 41(1):13-6. PubMed ID: 8202188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen-induced severe hypertriglyceridemia and pancreatitis.
    Elisaf MS; Nakou K; Liamis G; Pavlidis NA
    Ann Oncol; 2000 Aug; 11(8):1067-9. PubMed ID: 11038048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.
    Bays HE; McKenney JM; Dujovne CA; Schrott HG; Zema MJ; Nyberg J; MacDougall DE;
    Am J Cardiol; 2003 Sep; 92(5):538-43. PubMed ID: 12943873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer.
    Kusama M; Miyauchi K; Aoyama H; Sano M; Kimura M; Mitsuyama S; Komaki K; Doihara H
    Breast Cancer Res Treat; 2004 Nov; 88(1):1-8. PubMed ID: 15538040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe hypertriglyceridemia induced by tamoxifen].
    Taira M; Takasu N; Komiya I
    Nihon Ronen Igakkai Zasshi; 1998 Nov; 35(11):858-60. PubMed ID: 10064974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy.
    Akyol M; Alacacioglu A; Demir L; Kucukzeybek Y; Yildiz Y; Gumus Z; Kara M; Salman T; Varol U; Taskaynatan H; Oflazoglu U; Bayoglu V; Tarhan MO
    Cancer Biomark; 2017; 18(4):441-449. PubMed ID: 28106545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
    Saarto T; Blomqvist C; Ehnholm C; Taskinen MR; Elomaa I
    J Clin Oncol; 1996 Feb; 14(2):429-33. PubMed ID: 8636753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tamoxifen on serum lipid metabolism.
    Hozumi Y; Kawano M; Saito T; Miyata M
    J Clin Endocrinol Metab; 1998 May; 83(5):1633-5. PubMed ID: 9589669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossover trial for lipid abnormality in postmenopausal breast cancer patients during selective estrogen receptor modulators (SERMs) administrations.
    Kusama M; Kaise H; Nakayama S; Ota D; Misaka T; Aoki T
    Breast Cancer Res Treat; 2004 Nov; 88(1):9-16. PubMed ID: 15538041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative changes in serum lipid levels of breast cancer and adjuvant chemotherapy].
    Morimoto K; Koh M
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1517-24. PubMed ID: 15508443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.